Ian Shakil - 03 Dec 2021 Form 4 Insider Report for Augmedix, Inc.

Role
Chief Strategy Officer, Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
+$10,200
Form type
4
Filing time
03 Dec 2021, 13:45:31 UTC
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Award $10,200 +3,000 +1.4% $3.40 219,660 03 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.